REVIEW ARTIKEL: GEN SITOKROM YANG MEMPENGARUHI EFEKTIVITAS OBAT KONTRASEPSI DAN BERHUBUNGAN DENGAN VENOUS THROMBOEMBOLISM (VTE)
DOI:
https://doi.org/10.59024/jikas.v3i1.1118Abstract
One cardiovascular condition known as venous thromboembolism (VTE) is believed to be brought on by hormonal medications like oral contraceptives. Women taking oral contraceptives are more likely to develop VTE over the age of 40 due to a genetic predisposition that can trigger the risk from the cytochrome gene. One of the genes associated with VTE and contraception is the CYP2C19, CYP3A4, CYP1A2, and CYP345 genes. Methods: A quality assessment of the method and risk was conducted using The Joanna Briggs Institute (JBI) Instrument after a number of articles collected from Scopus, Crossref, Ebsco, Pubmed, Science Direct, and Google Scholar were selected by the inclusion criteria. Results:Articles or journals on the JBI instrument showed good quality in the number of 10 research particles. From the results of the journal analysis, several cytochrome genes were obtained, namely the CYP2C19, CYP3A4, CYP1A2, and CYP345 genes. Conclusion: Several types of cytochrome genes that affect oral use as well as VTE. The cytochrome CYP2C19 gene may decrease the effects of clopidogrel. The use of CYP3A4 gene-inducing drugs should be considered at the same time as contraception and it is advisable to use other drug alternatives. Concomitant use of CYP1A2 gene-inducing drugs with contraception should be avoided because they may decrease the contraceptive effect. The use of cyclosporine drugs needs to be monitored because cyclosporine can increase estrogen levels in the liver.
References
Alwahdy, A. S. et al. (2020) ‘Interaksi Hormon Dan Epilepsi’, Majalah Kedokteran Neurosains Perhimpunan Dokter Spesialis Saraf Indonesia, 37(2). doi: 10.52386/neurona.v37i2.115.
Fuad, Fawandi A, dkk. 2021. Review Artikel Analisis Kandungan Sildenafil Sitrat Dalam Sediaan Cair Jamu Kuat Dengan Metode Kromatografi Cair Kinerja Tinggi. Program Studi Sarjana Farmasi Universitas Surabaya MEDFARM: Jurnal Farmasi dan Kesehatan, Vol.10, No. 2, Des 2021, Hal,13-28
Lenicek Krleza, J., Jakovljevic, G., Bronic, A., Coen Herak, D., Bonevski, A., Stepan-Giljevic, J., & Roic, G. (2010). Contraception-related deep venous thrombosis and pulmonary embolism in a 17-Year-old girl heterozygous for factor V leiden, prothrombin G20210A mutation, MTHFR C677T and homozygous for PAI-1 mutation: report of a family with multiple genetic risk factors and review of the literature. Pathophysiology of Haemostasis and Thrombosis, 37(1), 24–29. https://doi.org/10.1159/000319051
Marian, A. J. (2009). Cytochrome p-450 polymorphisms and response to clopidogrel. Current Atherosclerosis Reports, 11(3), 157–160. https://doi.org/10.1007/s11883-009-0025-7
Tsuchiya, Y., Nakajima, M. and Yokoi, T. (2015) ‘Cytochrome P450-mediated metabolism of estrogens and its regulation in human’, Cancer Letters, 227(2), pp. 115–124. doi: 10.1016/j.canlet.2004.10.007.
Sandberg, M. (2014). The Impact Of CYP2C9 Genetics And Oral Contraceptives On Cytochrome P450 2C9 Phenotype. Drug Metabolism and Disposition, 32(5), 484–489. doi:10.1124/dmd.32.5.484.
Canonico, Marianne; Bouaziz, Elodie; Carcaillon, Laure; Verstuyft, Céline; Guiochon-Mantel, Anne; Becquemont, Laurent; Scarabin, Pierre-Yves (2008). Synergism between Oral Estrogen Therapy and Cytochrome P450 3A5*1 Allele on the Risk of Venous Thromboembolism among Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism, 93(8), 3082–3087. doi:10.1210/jc.2008-0450
Granfors, M; Backman, J; Laitila, J; Neuvonen, P (2005). Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2. Clinical Pharmacology & Therapeutics, 78(4), 400–411. doi:10.1016/j.clpt.2005.06.009
Bryk, Agata Hanna; Wypasek, Ewa; Plens, Krzysztof; Awsiuk, Magdalena; Undas, Anetta (2018). Bleeding predictors in patients following venous thromboembolism treated with vitamin K antagonists: Association with increased number of single nucleotide polymorphisms. Vascular Pharmacology, (), S1537189117302896–. doi:10.1016/j.vph.2018.02.002
Hudaya, Okky. (2019). Hubungan Kejadian Dvt (Deep Vein Trombosis) Berdasarkan Usg (Ultra Sonography) Dengan Pasien Rawatan Icu 72 Jam Yang Menggunakan Ventilasi Mekanik Di Icu Rsup. Haji Adam Malik Medan. Tesis Megister Program Magister Kedokteran Klinik Departemen Anestesiologi Dan Terapi Intensif Fk Universitas Sumatera Utara Rsup. Haji Adam Malik Medan.
Article, O. (2011). New gene variants associated with venous thrombosis : a replication study in White and Black Americans. December 2010, 489–495. https://doi.org/10.1111/j.1538-7836.2011.04185.x
Canonico, M., Bouaziz, E., Carcaillon, L., & Guiochon-mantel, A. (2015). Synergism between Oral Estrogen Therapy and Cytochrome P450 3A5 * 1 Allele on the Risk of Venous Thromboembolism among Postmenopausal Women. 93(August 2008), 3082–3087. https://doi.org/10.1210/jc.2008-0450
Granfors, M. T., Backman, J. T., Laitila, J., & Neuvonen, P. J. (2005). PHARMACOKINETICS AND DRUG DISPOSITION Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2. 400–411. https://doi.org/10.1016/j.clpt.2005.06.009
Shuldiner, A. R., Connell, J. R. O., Bliden, K. P., Ryan, K., Horenstein, R. B., Damcott, C. M., Pakyz, R., Tantry, U. S., Post, W., & Herzog, W. (2015). Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy. 302(8), 849–858.
Sunaga, T., Ms, B. C., Schmidt, S., & Pharmd, J. B. (2020). Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system. Contraception. https://doi.org/10.1016/j.contraception.2020.12.002
Yue, Y., Sun, Q., Man, C., & Fu, Y. (2019). Association of the CYP4V2 polymorphism rs13146272 with venous thromboembolism in a Chinese population. Clinical and Experimental Medicine, 19(1), 159–166. https://doi.org/10.1007/s10238-018-0529-y
Zhang, N., Shon, J., Kim, M., Yu, C., Zhang, L., Huang, S., Lee, L., & Tran, D. (2017). Role of CYP3A in Oral Contraceptives Clearance. July, 1–10. https://doi.org/10.1111/cts.12499
Abdalvand, A. (2014). Emergency (2014); 2(2): 53 53 The Risk of Venous Thromboembolism Associated with Oral Contraceptive; the Search Is Still On. Emergency, 2(2), 53. www.jemerg.com.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 JURNAL ILMIAH KESEHATAN MASYARAKAT DAN SOSIAL
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
